15 June 2021 - The HHS is proposing to rescind a Trump administration drug rule requiring community health centers to give all their insulin and epinephrine discounts to patients.

Centers that don’t pass on the savings wouldn’t qualify for federal grants under the rule. The Department of Health and Human Services under President Joe Biden delayed the effective date of the rule (RIN 0906-AB25) until July 20 to give agency officials more opportunity to review the rule and ensure it wouldn’t impede the agency’s and health centers’ “immediate priority work” of responding to the pandemic.

Read Bloomberg Law article